New studies show that first-generation COVID-19 vaccines effectively reduce severe disease but quickly lose their protective value.
In the context of the continuous emergence of SARS-CoV-2 coronavirus variants, and a potential fourth wave accelerating in Europe, these studies suggest enhancing COVID-19 vaccination coverage is still the most critical and urgent priority.
COVID-19 Vaccine Protection Wanes, But They Are Our Best Defense
ACR: Lupus Patients Can Have Low Immune Response to COVID-19 Vaccines
However, overall disease activity does not appear to change after vaccination
SSRIs Linked to Reduced Relative Risk for Mortality in COVID-19
Relative risks for mortality significantly reduced for any SSRI, fluoxetine, and fluoxetine or fluvoxamine
Prior SARS-CoV-2 Infection Ups Protection for Vaccinated
Prior infection linked to lower risk for breakthrough infection among individuals vaccinated with BNT162b2 or mRNA-1273
Federal Court Backs Stay on COVID-19 Vaccine Mandate for Large Businesses
Legal challenges against the mandate have been filed by at least 27 states in at least six federal appeals courts